Insulin aspart, recombinant Subcutaneous and Orazinc 220
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Orazinc 220 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zinc sulfate
Brand name: Orazinc 110, Orazinc 220, Zinc, Zinc-220, Zinca-pak, Mar-Zinc, Verazinc, Zincate, Zinc CR, Micro-Zn, Zinc 50 mg Pink
Synonyms: Orazinc 110
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Orbactiv
- Insulin aspart, recombinant Subcutaneous-Orbivan
- Insulin aspart, recombinant Subcutaneous-Orencia
- Insulin aspart, recombinant Subcutaneous-Orencia (Abatacept Auto-Injectors)
- Insulin aspart, recombinant Subcutaneous-Orencia (Abatacept Infusion)
- Insulin aspart, recombinant Subcutaneous-Orencia (Abatacept Prefilled Syringes)
- Orazinc 220-Insulin degludec
- Orazinc 220-Insulin Degludec (U-100) Prefilled Pens
- Orazinc 220-Insulin Degludec (U-100) Vials
- Orazinc 220-Insulin Degludec (U-200) Prefilled Pens
- Orazinc 220-Insulin degludec and liraglutide
- Orazinc 220-Insulin degludec and liraglutide Subcutaneous